As the COVID 19 pandemic evolves, scientists are learning more about the virus and how it affects us. cancer patients are slightly at a higher risk than others. Cancer patients are thought to be immunocompromised in which the capacity to fight back the diseases is not enough as an average person. Along with immunocompromised cancer patients of an older age presence of other comorbidities like heart diseases, Heart attack, Diabetes also makes the fight back power comparatively weaker.

If the cancer patient develops COVID – 19 infection the chances of organ related complication increases as some might have gone through treatment in terms of radiation therapy, or maybe kidney removal , or chemotherapy which automatically suppress the immunity.

Patients with cancer might be immunocompromised by the effects of antineoplastic therapy, supportive medications such as steroids, and the immunosuppressive properties of cancer itself

Journal of carcinogenesis & Mutagenesis is using Editorial Tracking System for quality in review process. Editorial Tracking is an online manuscript submission, review and tracking systems used by most of the best open access journals.

Review processing is performed by the editorial board members of carcinogenesis & Mutagenesis (Volume 11) or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript.

Authors are requested to submit their manuscripts as an e-mail attachment to mail

Our journal shares all the views and ideas about Cancer. If u has anything related to cancer patients during this COVID-19 pandemic era which will provide an awareness to several cancer patients, you can contact us.

Caring for those with cancer in the times of Covid-19.

Best regards
Editorial Team
Journal of Carcinogenesis & Mutagenesis
NLM ID: 101612108